|
Approved for Marketing
Elestrin™
low dose estradiol ATD™ gel
Medi-Jector VISION®
needle-free device for use with insulin
ZomaJet® 2 Vision
marketed by Ferring for hGH in Europe
Twin-Jector® EZ II
marketed by JCR Pharmaceuticals Co. Ltd. for hGH in Japan
SciTojet2™
marketed by SciGen Ltd. for hGH in Asia
Ibuprofen gel
in 11 countries
|
|
|
|
Improving Pharmaceuticals
Through
Advanced Drug Delivery Systems |
Antares Pharma is
committed to developing and commercializing novel therapeutic
products utilizing our unique, advanced drug delivery systems.
Our products are patient focused: they typically improve safety
and efficacy, reduce side effects and enable us to deliver a
lower dose. Our advanced drug delivery systems are also well
positioned for “life cycle extension” options. We believe that
we offer a distinct value to patients, physicians and our
shareholders.
|
|